Haleon PLC 5年每股股利增长率 % : 0.00% (今日)
Haleon PLC5年每股股利增长率 %(5-Year Dividend Growth Rate (Per Share))的相关内容及计算方法如下:
5年每股股利增长率 %是公司提高股息的平均年增长率。根据最近六年的年度数据,用最小二乘法回归计算得出。 截至今日, Haleon PLC 的 5年每股股利增长率 % 为 0.00%。
安全信号
股利分红: 股息率 % 接近2年高点
Haleon PLC 1年每股股利增长率 % 为 150.00%。
Haleon PLC 5年每股股利增长率 % (HLN 5年每股股利增长率 %) 行业比较
在专用医药制造(三级行业)中,Haleon PLC 5年每股股利增长率 %与其他类似公司的比较如下:
Haleon PLC 5年每股股利增长率 % (HLN 5年每股股利增长率 %) 分布区间
在医药制造(二级行业)和医疗保健(一级行业)中,Haleon PLC 5年每股股利增长率 %的分布区间如下:
Haleon PLC 5年每股股利增长率 % (HLN 5年每股股利增长率 %) 计算方法
5年每股股利增长率 %是公司提高股息的平均年增长率。根据最近六年的年度数据,用最小二乘法回归计算得出。
Haleon PLC 5年每股股利增长率 % (HLN 5年每股股利增长率 %) 解释说明
1. 股息支付率 又称“股利分配率”或“股利发放率”,是向股东分派的股息占公司盈利的比率。它反映公司的股利分配政策和股利支付能力。
2. 股息率 % 是过去12个月的股息与当前股价之间的比率。在投资实践中,股息率是衡量企业是否具有投资价值的重要标尺之一。
安全信号
股利分红: 股息率 % 接近2年高点
Haleon PLC 5年每股股利增长率 % (HLN 5年每股股利增长率 %) 相关词条
感谢查看价值大师中文站为您提供的Haleon PLC5年每股股利增长率 %的详细介绍,请点击以下链接查看与Haleon PLC5年每股股利增长率 %相关的其他词条:
Haleon PLC (HLN) 公司简介
一级行业:医疗保健
二级行业:医药制造
公司网站:https://www.haleon.com
公司地址:The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
公司简介:Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
二级行业:医药制造
公司网站:https://www.haleon.com
公司地址:The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
公司简介:Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.